{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:49:46Z","timestamp":1787017786256,"version":"build-2736575974"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,2]]},"abstract":"<jats:p>In cells, highly coordinated multivalent interactions give rise to discrete functional assemblies\u2014commonly referred to as biomolecular condensates\u2014that compartmentalize the molecular components required for specific biological reactions. These condensates are increasingly recognized as organizational entities with central roles in normal cellular regulation and in the pathogenesis of human cancers. In a recent issue of Cell, Datar and colleagues investigated the condensation of NPM1c, a common gene mutation in acute myeloid leukemias (AML). They demonstrated the necessity and sufficiency of NPM1c in forming nuclear condensates termed coordinating bodies (C-body), which show copartitioning of a suite of transcriptional coactivators such as NUP98, KMT2A\/MLL1, menin, and XPO1\/CRM1. While C-bodies are necessary for driving NPM1c-mutant AMLs, blockade of the copartitioned components within C-bodies, such as the XPO1\/CRM1 or menin interaction by inhibitors, significantly alters the condensate composition and functionality. Likewise, a systematic deletion study of various regions within NPM1c pointed to a role for the coordinated multivalent interaction in establishing the functional condensates, as previously reported in studies of the Wilms tumor-causing ENL mutants and AML-causing NUP98 oncofusions. Comixing of C-bodies and condensates formed by the oncofusion of NUP98 or KMT2A\/MLL1 in cells suggested they are biophysically indistinguishable, indicative of a shared pathogenic mechanism. Altogether, recent studies of multiple genetic drivers in human cancers have revealed a type of chromatin-bound multicomponent onco-condensate, which may motivate the development of onco-condensate disruptors that could potentially be used as broad treatments for cancer.<\/jats:p>","DOI":"10.1158\/0008-5472.can-25-5871","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T15:45:50Z","timestamp":1767368750000},"page":"1543-1544","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Unified Model: Chromatin-Bound Multicomponent Condensates"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1871-2439","authenticated-orcid":false,"given":"Benjamin K.","family":"Lau","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University School of Medicine 1 Department of Pharmacology and Cancer Biology, , Durham, North Carolina."},{"name":"2UNC MD-PhD Program, University of North Carolina School of Medicine, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0496-6203","authenticated-orcid":false,"given":"Elena L.","family":"Haarer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University School of Medicine 3 Medical Scientist Training Program, , Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-1792","authenticated-orcid":false,"given":"Jeong Hyun","family":"Ahn","sequence":"additional","affiliation":[{"name":"4Department of Biomarker Discovery, PROTEINA Co., Ltd, Seoul, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7210-9940","authenticated-orcid":false,"given":"Gang Greg","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University School of Medicine 1 Department of Pharmacology and Cancer Biology, , Durham, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University School of Medicine 3 Medical Scientist Training Program, , Durham, North Carolina."},{"id":[{"id":"https:\/\/ror.org\/00py81415","id-type":"ROR","asserted-by":"publisher"}],"name":"Duke University School of Medicine 5 Duke Cancer Institute, , Durham, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"2026040203110533400_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/2159-8290.CD-22-0424","article-title":"Mutant NPM1 hijacks transcriptional hubs to maintain pathogenic gene programs in acute myeloid leukemia","volume":"13","author":"Wang","year":"2023","journal-title":"Cancer Discov"},{"key":"2026040203110533400_bib2","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1016\/j.cell.2025.10.010","article-title":"Disparate leukemia mutations converge on nuclear phase-separated condensates","volume":"188","author":"Datar","year":"2025","journal-title":"Cell"},{"key":"2026040203110533400_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.trecan.2023.05.006","article-title":"Onco-condensates: formation, multi-component organization, and biological functions","volume":"9","author":"Xu","year":"2023","journal-title":"Trends Cancer"},{"key":"2026040203110533400_bib4","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.molcel.2022.09.034","article-title":"Hotspot mutations in the structured ENL YEATS domain link aberrant transcriptional condensates and cancer","volume":"82","author":"Song","year":"2022","journal-title":"Mol Cell"},{"key":"2026040203110533400_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","article-title":"Phase separation drives aberrant chromatin looping and cancer development","volume":"595","author":"Ahn","year":"2021","journal-title":"Nature"},{"key":"2026040203110533400_bib6","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.molcel.2024.12.026","article-title":"The phenylalanine-and-glycine repeats of NUP98 oncofusions form condensates that selectively partition transcriptional coactivators","volume":"85","author":"Ahn","year":"2025","journal-title":"Mol Cell"},{"key":"2026040203110533400_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1158\/2159-8290.CD-21-0674","article-title":"Phase separation mediates NUP98 fusion oncoprotein leukemic transformation","volume":"12","author":"Chandra","year":"2022","journal-title":"Cancer Discov"},{"key":"2026040203110533400_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41594-020-00550-w","article-title":"Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression","volume":"28","author":"Terlecki-Zaniewicz","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"2026040203110533400_bib9","doi-asserted-by":"crossref","first-page":"112884","DOI":"10.1016\/j.celrep.2023.112884","article-title":"Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1\/CRM1 and rearrangement of 3D genome structure","volume":"42","author":"Oka","year":"2023","journal-title":"Cell Rep"},{"issue":"Suppl 1","key":"2026040203110533400_bib10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2025-865","article-title":"Wildtype NUP98 cooperates with NPM1c to drive oncogenic transcription","volume":"146","author":"Gama","year":"2025","journal-title":"Blood"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-5871\/3723202\/can-25-5871.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/7\/1543\/3753509\/can-25-5871.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/7\/1543\/3753509\/can-25-5871.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:11:15Z","timestamp":1775113875000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/7\/1543\/775639\/A-Unified-Model-Chromatin-Bound-Multicomponent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,1,2]]},"published-print":{"date-parts":[[2026,4,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-5871","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}